Innoprot receives the Supplier Recognition Award 2025 from Scientist.com
The recognition highlights exceptional performance in research services for drug discovery. It reflects the commitment to scientific research and customer satisfaction.
See the latest news and media coverage for Innoprot. We track all announcements, press releases, and industry mentions in real time, all in one place.
Provider of cell-based assays and primary cells
innoprot.comLast updated
In short: Innoprot advanced drug discovery research, received the 2025 Scientist.com Supplier Recognition Award, and secured Basque Government funding.
The recognition highlights exceptional performance in research services for drug discovery. It reflects the commitment to scientific research and customer satisfaction.
The complex shows greater antidepressant, analgesic, and neuroprotective activity than commercial ALC. It crosses the blood-brain barrier and protects against excitotoxicity.
The new preservative-free ophthalmic formulation preserves the epithelial integrity of the ocular surface in a comparative in vitro study. Published in Scientific Reports on April 26, 2024.
The study characterizes its neurogenic and neuroprotective effects in stem cell models of Alzheimer's disease. Published in Stem Cell Research & Therapy.
how InvestingPro’s fair value caught Innodata before 49% decline...
Innodata Inc. recently entered a fourth amendment to its credit agreement with Wells Fargo, boosting its secured revolving credit facility to up to US$50,000,000 and...
The Basque company develops products and multiplexing technologies of cellular systems "in vitro" to carry out assays in drug discovery and development. Specialized...
Track Innoprot and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Innoprot and other trending companies.